Trials / Terminated
TerminatedNCT03537222
Quality of Life in Patients With Multiple Myeloma-validation Study
Validation of the Myeloma Patient Outcome Scale (MyPOS) Assessing the Quality of Life in Patients With Multiple Myeloma in the German Speaking Part of Switzerland
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Zurich University of Applied Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
In this study, the Myeloma Patient Outcome Scale (MyPOS) will be translated from English to German. This translated version will be quantitatively and qualitatively validated with patients with multiple myeloma.
Detailed description
Patients with multiple myeloma (N=10) will be interviewed in the qualitative phase about their comprehension of the translated MyPOS. The questionnaire will be revised according to the results of the interviews. This culturally adapted Swiss-German MyPOS will be assessed in the quantitative phase for its' psychometric properties with 200 patients with multiple myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Myeloma Patient Outcome Scale (MyPOS) | Patients complete the MyPOS questionnaire on quality of life |
Timeline
- Start date
- 2018-10-10
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2018-05-25
- Last updated
- 2021-10-14
Locations
3 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03537222. Inclusion in this directory is not an endorsement.